Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.08)
# 3,525
Out of 4,829 analysts
790
Total ratings
27.03%
Success rate
-17.19%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATNM Actinium Pharmaceuticals | Reiterates: Buy | $4 | $1.53 | +161.44% | 30 | May 12, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $32 → $20 | $1.84 | +986.96% | 28 | May 9, 2025 | |
| CLDX Celldex Therapeutics | Maintains: Buy | $80 → $50 | $19.55 | +155.75% | 33 | May 9, 2025 | |
| ITRM Iterum Therapeutics | Assumes: Buy | $9 | $1.02 | +782.44% | 1 | May 8, 2025 | |
| KRYS Krystal Biotech | Reiterates: Buy | $240 | $136.50 | +75.82% | 30 | May 6, 2025 | |
| BMEA Biomea Fusion | Maintains: Buy | $40 → $18 | $1.74 | +934.48% | 30 | May 6, 2025 | |
| NVCT Nuvectis Pharma | Reiterates: Buy | $11 → $15 | $8.14 | +84.39% | 9 | Apr 30, 2025 | |
| KURA Kura Oncology | Reiterates: Buy | $40 | $6.04 | +562.80% | 26 | Apr 28, 2025 | |
| VYNE VYNE Therapeutics | Maintains: Buy | $5.75 → $4.5 | $1.26 | +257.14% | 22 | Apr 25, 2025 | |
| TNYA Tenaya Therapeutics | Reiterates: Buy | $5 | $0.41 | +1,128.80% | 16 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $0.79 | +1,936.14% | 28 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $102 | $28.14 | +262.47% | 32 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $2.00 | +1,103.01% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $32.21 | +272.56% | 48 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.62 | +517.28% | 2 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $6.58 | +143.35% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.09 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $2.68 | +1,057.11% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $0.52 | +3,942.35% | 14 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.60 | +1,895.01% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.98 | +707.06% | 11 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $26 | $3.11 | +736.01% | 12 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.69 | +481.06% | 21 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $25.10 | +314.38% | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $13 | $1.31 | +896.17% | 30 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.96 | - | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $9.71 | +281.05% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $77 | $6.94 | +1,009.51% | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.47 | +648.30% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.30 | +3,199.79% | 2 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $3.30 | +960.61% | 7 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $4.59 | +248.58% | 19 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.1 | $4.17 | -1.56% | 18 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.48 | +1,782.85% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $18.94 | +200.95% | 26 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $21 | $4.84 | +333.88% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.63 | +1,126.99% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.40 | +400.00% | 14 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.88 | +768.06% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.22 | +575.68% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $106.21 | - | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $1.65 | +1,475.76% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $32 | $14.30 | +123.78% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.89 | +376.19% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.13 | +506.06% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.13 | +8,747.99% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.63 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.69 | +1,793.49% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $2.47 | +1,114.57% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.96 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $33.95 | -2.80% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $6.79 | +1,048.75% | 1 | Mar 24, 2017 |
Actinium Pharmaceuticals
May 12, 2025
Reiterates: Buy
Price Target: $4
Current: $1.53
Upside: +161.44%
Iovance Biotherapeutics
May 9, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $1.84
Upside: +986.96%
Celldex Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $80 → $50
Current: $19.55
Upside: +155.75%
Iterum Therapeutics
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $1.02
Upside: +782.44%
Krystal Biotech
May 6, 2025
Reiterates: Buy
Price Target: $240
Current: $136.50
Upside: +75.82%
Biomea Fusion
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.74
Upside: +934.48%
Nuvectis Pharma
Apr 30, 2025
Reiterates: Buy
Price Target: $11 → $15
Current: $8.14
Upside: +84.39%
Kura Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $40
Current: $6.04
Upside: +562.80%
VYNE Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $5.75 → $4.5
Current: $1.26
Upside: +257.14%
Tenaya Therapeutics
Apr 25, 2025
Reiterates: Buy
Price Target: $5
Current: $0.41
Upside: +1,128.80%
Apr 25, 2025
Reiterates: Buy
Price Target: $16
Current: $0.79
Upside: +1,936.14%
Apr 24, 2025
Reiterates: Buy
Price Target: $102
Current: $28.14
Upside: +262.47%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $2.00
Upside: +1,103.01%
Apr 21, 2025
Reiterates: Buy
Price Target: $120
Current: $32.21
Upside: +272.56%
Apr 14, 2025
Reiterates: Buy
Price Target: $10
Current: $1.62
Upside: +517.28%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $6.58
Upside: +143.35%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.09
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $2.68
Upside: +1,057.11%
Apr 4, 2025
Reiterates: Buy
Price Target: $21
Current: $0.52
Upside: +3,942.35%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.60
Upside: +1,895.01%
Apr 1, 2025
Reiterates: Buy
Price Target: $16
Current: $1.98
Upside: +707.06%
Mar 31, 2025
Maintains: Buy
Price Target: $9 → $26
Current: $3.11
Upside: +736.01%
Mar 28, 2025
Reiterates: Buy
Price Target: $4
Current: $0.69
Upside: +481.06%
Mar 28, 2025
Reiterates: Buy
Price Target: $104
Current: $25.10
Upside: +314.38%
Mar 27, 2025
Maintains: Buy
Price Target: $21 → $13
Current: $1.31
Upside: +896.17%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.96
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $9.71
Upside: +281.05%
Mar 20, 2025
Reiterates: Buy
Price Target: $77
Current: $6.94
Upside: +1,009.51%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.47
Upside: +648.30%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.30
Upside: +3,199.79%
Mar 14, 2025
Reiterates: Buy
Price Target: $35
Current: $3.30
Upside: +960.61%
Mar 11, 2025
Reiterates: Buy
Price Target: $16
Current: $4.59
Upside: +248.58%
Mar 11, 2025
Downgrades: Neutral
Price Target: $4.1
Current: $4.17
Upside: -1.56%
Mar 11, 2025
Reiterates: Buy
Price Target: $9
Current: $0.48
Upside: +1,782.85%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $18.94
Upside: +200.95%
Feb 4, 2025
Maintains: Buy
Price Target: $8 → $21
Current: $4.84
Upside: +333.88%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.63
Upside: +1,126.99%
Dec 19, 2024
Reiterates: Buy
Price Target: $7
Current: $1.40
Upside: +400.00%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.88
Upside: +768.06%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.22
Upside: +575.68%
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $106.21
Upside: -
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.65
Upside: +1,475.76%
Nov 11, 2024
Maintains: Buy
Price Target: $3 → $32
Current: $14.30
Upside: +123.78%
Nov 11, 2024
Reiterates: Buy
Price Target: $9
Current: $1.89
Upside: +376.19%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $4.13
Upside: +506.06%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.13
Upside: +8,747.99%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.63
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.69
Upside: +1,793.49%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $2.47
Upside: +1,114.57%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.96
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $33.95
Upside: -2.80%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $6.79
Upside: +1,048.75%